Which symptoms are serious adverse effects of administering apomorphine to a patient with Parkinson's disease? Select all that apply. One, some, or all responses may be correct. \( \square \) Chorea \( \square \) Facial grimacing \( \square \) Seizure disorders \( \square \) Chewing motions \( \square \) Rocking movements

When administering apomorphine to a patient with Parkinson's disease, several serious adverse effects should be monitored. Apomorphine is a potent dopamine agonist used to manage "off" episodes in Parkinson's disease but can lead to various movement-related side effects as well as other serious conditions. **Serious Adverse Effects of Apomorphine:** 1. **Chorea**: This refers to involuntary, irregular, and unpredictable movements which can be distressing and impair daily functioning. 2. **Facial Grimacing**: Also a form of dyskinesia, facial grimacing can affect facial expressions and overall quality of life. 3. **Seizure Disorders**: Although less common, seizures are a serious adverse effect that can result from apomorphine therapy. 4. **Chewing Motions**: Known as orofacial dyskinesia, these involuntary chewing movements can interfere with eating and speaking. **Non-Serious or Less Common Effects:** - **Rocking Movements**: This is not typically associated with apomorphine use and is not recognized as a common serious adverse effect. **Summary:** The serious adverse effects of apomorphine in Parkinson's disease include **Chorea**, **Facial Grimacing**, **Seizure Disorders**, and **Chewing Motions**. **Rocking Movements** are not generally considered a serious adverse effect related to apomorphine. **Correct Selections:** - □ Chorea - □ Facial grimacing - □ Seizure disorders - □ Chewing motions *Rocking movements are not typically recognized as a serious adverse effect of apomorphine.*